• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

直肠癌的保肛问题:所有问题都得到解答了吗?

Organ preservation in rectal cancer: have all questions been answered?

机构信息

Department of Clinical Oncology, Leiden University Medical Center, Leiden, Netherlands.

出版信息

Lancet Oncol. 2015 Jan;16(1):e13-22. doi: 10.1016/S1470-2045(14)70398-5. Epub 2014 Dec 29.

DOI:10.1016/S1470-2045(14)70398-5
PMID:25638548
Abstract

Improved treatment strategies have eliminated local control as the major problem in rectal cancer. With increasing awareness of long-term toxic effects in survivors of rectal cancer, organ-preservation strategies are becoming more popular. After chemoradiotherapy, both watchful waiting and local excision are used as possible alternatives for radical surgery. Although these seem attractive strategies, many issues about the safety of organ preservation remain. Additionally, radiotherapy strategies are mainly aimed at intermediate and high-risk rectal tumours, and adaptation of this standard practice for a completely new treatment indication has yet to start. This Review will discuss the options and problems of organ preservation, and address the research questions that need to be answered in the coming years, with a specific focus on radiotherapy.

摘要

改良的治疗策略已经消除了直肠癌局部控制的主要问题。随着人们对直肠癌幸存者长期毒性影响认识的提高,保留器官的策略越来越受欢迎。在放化疗后,观察等待和局部切除都被用作根治性手术的可能替代方法。尽管这些方法似乎很有吸引力,但保留器官的安全性仍存在许多问题。此外,放疗策略主要针对中高危直肠肿瘤,这种标准治疗方法的应用尚未开始针对全新的治疗指征。本文将讨论保留器官的选择和问题,并讨论未来几年需要回答的研究问题,特别关注放疗。

相似文献

1
Organ preservation in rectal cancer: have all questions been answered?直肠癌的保肛问题:所有问题都得到解答了吗?
Lancet Oncol. 2015 Jan;16(1):e13-22. doi: 10.1016/S1470-2045(14)70398-5. Epub 2014 Dec 29.
2
Is there a place for organ preservation in infiltrating rectal cancer?在浸润性直肠癌中,器官保存有一席之地吗?
Minerva Chir. 2015 Aug;70(4):283-96. Epub 2015 Apr 21.
3
Organ preservation with local excision or active surveillance following chemoradiotherapy for rectal cancer.直肠癌放化疗后采用局部切除或主动监测进行器官保留。
Br J Cancer. 2017 Jan 17;116(2):169-174. doi: 10.1038/bjc.2016.417. Epub 2016 Dec 20.
4
Management of Rectal Cancer Without Radical Resection.直肠癌非根治性切除术的治疗方法。
Annu Rev Med. 2017 Jan 14;68:169-182. doi: 10.1146/annurev-med-062915-021419. Epub 2016 Sep 9.
5
Advances in organ preserving strategies in rectal cancer patients.直肠癌患者保肛策略的研究进展。
Eur J Surg Oncol. 2018 Feb;44(2):209-219. doi: 10.1016/j.ejso.2017.11.024. Epub 2017 Dec 12.
6
Locally advanced rectal cancer: the importance of a multidisciplinary approach.局部进展期直肠癌:多学科方法的重要性。
World J Gastroenterol. 2014 Dec 14;20(46):17279-87. doi: 10.3748/wjg.v20.i46.17279.
7
Advances and challenges in treatment of locally advanced rectal cancer.局部晚期直肠癌治疗的进展与挑战
J Clin Oncol. 2015 Jun 1;33(16):1797-808. doi: 10.1200/JCO.2014.60.1054. Epub 2015 Apr 27.
8
[Downstaging after neoadjuvant therapy for rectal cancer modifies the planned original surgery].直肠癌新辅助治疗后的降期改变了原计划的手术方式
G Chir. 2008 Jun-Jul;29(6-7):277-80.
9
Clinicopathological analysis of distal margin for rectal cancer after preoperative chemoradiation therapy.术前放化疗后直肠癌远端切缘的临床病理分析
Hepatogastroenterology. 2012 Oct;59(119):2142-6. doi: 10.5754/hge11840.
10
Utility Scores and Preferences for Surgical and Organ-Sparing Approaches for Treatment of Intermediate and High-Risk Rectal Cancer.治疗中高危直肠肿瘤的手术和保器官方法的效用评分和偏好。
Dis Colon Rectum. 2018 Aug;61(8):911-919. doi: 10.1097/DCR.0000000000001029.

引用本文的文献

1
Non-invasive multimodal CT deep learning biomarker to predict pathological complete response of non-small cell lung cancer following neoadjuvant immunochemotherapy: a multicenter study.多模态 CT 深度学习标志物无创预测新辅助免疫化疗后非小细胞肺癌的病理完全缓解:一项多中心研究。
J Immunother Cancer. 2024 Sep 3;12(9):e009348. doi: 10.1136/jitc-2024-009348.
2
CT-based quantification of intratumoral heterogeneity for predicting pathologic complete response to neoadjuvant immunochemotherapy in non-small cell lung cancer.基于 CT 的肿瘤内异质性定量分析预测非小细胞肺癌新辅助免疫化疗的病理完全缓解。
Front Immunol. 2024 Jun 12;15:1414954. doi: 10.3389/fimmu.2024.1414954. eCollection 2024.
3
Image-based artificial intelligence for the prediction of pathological complete response to neoadjuvant chemoradiotherapy in patients with rectal cancer: a systematic review and meta-analysis.
基于图像的人工智能在预测直肠癌新辅助放化疗病理完全缓解中的应用:系统评价和荟萃分析。
Radiol Med. 2024 Apr;129(4):598-614. doi: 10.1007/s11547-024-01796-w. Epub 2024 Mar 21.
4
A study on the radiomic correlation between CBCT and pCT scans based on modified 3D-RUnet image segmentation.一项基于改进的3D-RUnet图像分割的CBCT与pCT扫描之间的影像组学相关性研究。
Front Oncol. 2024 Feb 22;14:1301710. doi: 10.3389/fonc.2024.1301710. eCollection 2024.
5
Performance reporting design in artificial intelligence studies using image-based TNM staging and prognostic parameters in rectal cancer: a systematic review.基于图像的TNM分期和直肠癌预后参数的人工智能研究中的性能报告设计:一项系统综述
Ann Coloproctol. 2024 Feb;40(1):13-26. doi: 10.3393/ac.2023.00892.0127. Epub 2024 Feb 28.
6
The watch-and-wait strategy radical resection for rectal cancer patients with a good response (≤ycT2) after neoadjuvant chemoradiotherapy.对于新辅助放化疗后反应良好(≤ycT2)的直肠癌患者,采用观察等待策略而非根治性切除术。
Ann Surg Treat Res. 2022 Dec;103(6):350-359. doi: 10.4174/astr.2022.103.6.350. Epub 2022 Dec 8.
7
Artificial intelligence with magnetic resonance imaging for prediction of pathological complete response to neoadjuvant chemoradiotherapy in rectal cancer: A systematic review and meta-analysis.人工智能结合磁共振成像预测直肠癌新辅助放化疗后的病理完全缓解:一项系统评价和荟萃分析。
Front Oncol. 2022 Oct 12;12:1026216. doi: 10.3389/fonc.2022.1026216. eCollection 2022.
8
Development and Validation of a Predictive Model for Toxicity of Neoadjuvant Chemoradiotherapy in Rectal Cancer in the CAO/ARO/AIO-04 Phase III Trial.CAO/ARO/AIO-04 三期试验中直肠癌新辅助放化疗毒性预测模型的开发与验证
Cancers (Basel). 2022 Sep 12;14(18):4425. doi: 10.3390/cancers14184425.
9
Establishment and validation of nomograms for predicting mesorectal lymph node staging and restaging.建立和验证预测中直肠淋巴结分期和再分期的列线图。
Int J Colorectal Dis. 2022 Sep;37(9):2069-2083. doi: 10.1007/s00384-022-04244-1. Epub 2022 Aug 26.
10
Multimodal Treatment of Rectal Cancer.直肠癌的多模态治疗。
Dtsch Arztebl Int. 2022 Aug 22;119(33-34):570-580. doi: 10.3238/arztebl.m2022.0254.